Bolt Biotherap Rg

Bolt Biotherapeutics is a clinical‑stage biopharma focused on cancer immunotherapies, advancing HER2‑targeted BDC‑1001, CRC/NSCLC BDC‑2034, and a next‑generation claudin 18.2 platform for gastric and pancreatic cancers, backed by collaborations with Genmab and Stanford.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 40
HQ: Redwood City

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BOLT	Bolt Biotherap Rg Cap: 0.0B	EQUITY	NMS	USD	US0977021049	Active	📈